JP2006527234A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006527234A5 JP2006527234A5 JP2006515986A JP2006515986A JP2006527234A5 JP 2006527234 A5 JP2006527234 A5 JP 2006527234A5 JP 2006515986 A JP2006515986 A JP 2006515986A JP 2006515986 A JP2006515986 A JP 2006515986A JP 2006527234 A5 JP2006527234 A5 JP 2006527234A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- hydroxy tamoxifen
- scars
- scar
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47661803P | 2003-06-09 | 2003-06-09 | |
| PCT/EP2004/006583 WO2004110420A1 (en) | 2003-06-09 | 2004-06-02 | Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006527234A JP2006527234A (ja) | 2006-11-30 |
| JP2006527234A5 true JP2006527234A5 (https=) | 2007-07-12 |
| JP4682129B2 JP4682129B2 (ja) | 2011-05-11 |
Family
ID=33551623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006515986A Expired - Lifetime JP4682129B2 (ja) | 2003-06-09 | 2004-06-02 | ４−ヒドロキシタモキシフェンによる過剰瘢痕化の治療及び予防 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7767717B2 (https=) |
| EP (1) | EP1631275B1 (https=) |
| JP (1) | JP4682129B2 (https=) |
| AT (1) | ATE393625T1 (https=) |
| AU (1) | AU2004246812B8 (https=) |
| CA (1) | CA2528431C (https=) |
| DE (1) | DE602004013439T2 (https=) |
| DK (1) | DK1631275T3 (https=) |
| ES (1) | ES2304610T3 (https=) |
| NZ (1) | NZ544031A (https=) |
| PT (1) | PT1631275E (https=) |
| WO (1) | WO2004110420A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004054557A2 (en) * | 2002-12-18 | 2004-07-01 | Laboratoires Besins International | Treatment of mastalgia with 4-hydroxy tamoxifen |
| JP4684655B2 (ja) | 2002-12-18 | 2011-05-18 | ラボラトワール ブザン アンテルナスィヨナル | ４−ヒドロキシタモキシフェンによる乳房密度低下 |
| CA2519980C (en) * | 2003-04-01 | 2012-04-10 | Laboratoires Besins International | Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| US7968532B2 (en) | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| PL1694319T3 (pl) * | 2003-12-15 | 2009-01-30 | Besins Healthcare Lu Sarl | Zastosowanie 4-hydroksytamoksyfenu do wytwarzania leku do leczenia ginekomastii |
| EP1579857A1 (en) * | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Chemically stable compositions of 4-hydroxy tamoxifen |
| US7507769B2 (en) * | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| EP1647271A1 (en) * | 2004-10-14 | 2006-04-19 | Laboratoires Besins International | 4-Hydroxy tamoxifen gel formulations |
| JP5189093B2 (ja) * | 2006-07-31 | 2013-04-24 | ラボラトワール・ベザン・ザンテルナショナル | 過剰瘢痕化の治療および予防 |
| EP1891945A1 (en) * | 2006-07-31 | 2008-02-27 | Laboratoires Besins International | Treatment and prevention of excessive scarring |
| CA2710232A1 (en) * | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Treatment of abnormal or excessive scars |
| AU2008343758A1 (en) * | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars |
| US20140350106A1 (en) * | 2013-05-22 | 2014-11-27 | Professional Compounding Centers Of America | Urea Silicone Gel for Scars and Hydration Treatment and Method of Using Same |
| US20140350117A1 (en) * | 2013-05-22 | 2014-11-27 | Professional Compounding Centers Of America | Topical Scar Treatment Composition and Method of Using Same |
| CN111163784B (zh) * | 2017-09-01 | 2024-07-26 | 黄玲惠 | 用于治疗蟹足肿的药物组合物及其用途 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558373B1 (fr) | 1984-01-20 | 1987-07-03 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
| ATE80152T1 (de) | 1987-04-21 | 1992-09-15 | Heumann Pharma Gmbh & Co | Stabile loesungsmitteladdukte von z-1-(p-betadimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl) 2-phenylbut-1-en. |
| US5045553A (en) | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
| DE3836862A1 (de) | 1988-10-27 | 1990-05-03 | Schering Ag | Mittel zur transdermalen applikation von steroidhormonen |
| JP3149180B2 (ja) * | 1989-07-31 | 2001-03-26 | マサチユセツツ・インスチチユート・オブ・テクノロジー | 瘢痕治療のためのカルシウム拮抗薬の使用 |
| TW218849B (https=) | 1991-05-17 | 1994-01-11 | Bristol Myers Squibb Co | |
| WO1994002130A1 (en) * | 1992-07-20 | 1994-02-03 | Massachusetts Institute Of Technology | Control of wound scar production with calcium antagonists alone or in a combination with a steroid |
| US5552162A (en) * | 1993-02-09 | 1996-09-03 | Arch Development Corporation | Method for improvement of scar size and appearance |
| US5613958A (en) | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| US5720963A (en) | 1994-08-26 | 1998-02-24 | Mary Kay Inc. | Barrier disruption treatments for structurally deteriorated skin |
| EP1043986B1 (en) * | 1997-12-23 | 2003-04-16 | Hexal Ag | Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin |
| US6013270A (en) | 1998-04-20 | 2000-01-11 | The Procter & Gamble Company | Skin care kit |
| DE10033853A1 (de) | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| PT1317921E (pt) | 2001-12-07 | 2009-11-06 | Besins Mfg Belgium | Composição farmacêutica sob a forma de gel ou de solução à base de di-hidrotestosterona, seu processo de preparação e suas utilizações |
| JP4684655B2 (ja) | 2002-12-18 | 2011-05-18 | ラボラトワール ブザン アンテルナスィヨナル | ４−ヒドロキシタモキシフェンによる乳房密度低下 |
| WO2004054557A2 (en) | 2002-12-18 | 2004-07-01 | Laboratoires Besins International | Treatment of mastalgia with 4-hydroxy tamoxifen |
| CA2519980C (en) | 2003-04-01 | 2012-04-10 | Laboratoires Besins International | Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| US7968532B2 (en) | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| EP1579857A1 (en) | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Chemically stable compositions of 4-hydroxy tamoxifen |
| US7507769B2 (en) | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| EP1579856A1 (en) | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| EP1647271A1 (en) | 2004-10-14 | 2006-04-19 | Laboratoires Besins International | 4-Hydroxy tamoxifen gel formulations |
-
2004
- 2004-06-02 US US10/858,399 patent/US7767717B2/en active Active
- 2004-06-02 PT PT04740032T patent/PT1631275E/pt unknown
- 2004-06-02 DK DK04740032T patent/DK1631275T3/da active
- 2004-06-02 AU AU2004246812A patent/AU2004246812B8/en not_active Expired
- 2004-06-02 WO PCT/EP2004/006583 patent/WO2004110420A1/en not_active Ceased
- 2004-06-02 NZ NZ544031A patent/NZ544031A/en not_active IP Right Cessation
- 2004-06-02 AT AT04740032T patent/ATE393625T1/de active
- 2004-06-02 DE DE602004013439T patent/DE602004013439T2/de not_active Expired - Lifetime
- 2004-06-02 EP EP04740032A patent/EP1631275B1/en not_active Expired - Lifetime
- 2004-06-02 JP JP2006515986A patent/JP4682129B2/ja not_active Expired - Lifetime
- 2004-06-02 CA CA2528431A patent/CA2528431C/en not_active Expired - Lifetime
- 2004-06-02 ES ES04740032T patent/ES2304610T3/es not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7145363B2 (ja) | 局所皮膜形成スプレー | |
| JP2006527234A5 (https=) | ||
| ES2377134T3 (es) | Preparación tópica de enfriamiento en forma de parche | |
| JP2023523155A (ja) | 慢性疼痛治療のためのカンナビジオール及び／又はテトラヒドロカンナビノールを含有する経皮製剤及び／又は局所製剤 | |
| JP2009542657A5 (https=) | ||
| US20100292199A1 (en) | Transcutaneous pharmaceutical compositions containing a steroid hormone | |
| BR112012029959A2 (pt) | compostos de carbamato de mentila como ativos para clareamento de pele e/ou cabelo | |
| JP2001513543A (ja) | 皮膚への局所適用のための非ステロイド性抗炎症薬製剤 | |
| JP4987209B2 (ja) | 瘢痕形成作用を有する医薬品を製造するためのビグアニド誘導体の使用 | |
| JP2008508339A (ja) | フェニトイン製剤および創傷治癒におけるその使用 | |
| WO1993009768A1 (fr) | Fomentation contenant du cetorolac | |
| JP6196704B2 (ja) | 神経因性疾病の治療のための医薬 | |
| JP2020500915A (ja) | 末梢神経障害性疼痛の治療に使用するための局所作用用フェニトイン | |
| CA2528431A1 (en) | Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen | |
| RU2007101538A (ru) | Применение фармацевтической композиции, содержащей кальцитриол и пропионат клобетазола, для лечения псориаза | |
| RU2013157834A (ru) | Композиции для подкожного введения физиологически активных средств | |
| JP2669951B2 (ja) | 麻薬性鎮痛剤を含有する経皮吸収組成物 | |
| US20190314325A1 (en) | Process and Method to Accelerate Cellular Regeneration, Healing and Wound Management | |
| CN112999199A (zh) | 酮咯酸氨丁三醇凝胶贴膏的制备及应用 | |
| JPH0640947A (ja) | 経皮吸収製剤用組成物および経皮吸収製剤 | |
| EA007351B1 (ru) | Фармацевтическая композиция для чрескожной доставки физиологически активных агентов | |
| AU2015349153B2 (en) | Application of levalbuterol formulation in treatment of skin and mucous membrane traumatic ulcers | |
| CN115737609A (zh) | 一种含草乌甲素凝胶贴膏及其制备方法 | |
| JP2764261B2 (ja) | 外用消炎鎮痛剤 | |
| RU2160092C2 (ru) | Антимикробный препарат для лечения инфицированных ран |